Nuveen, LLC Theravance Biopharma, Inc. Transaction History

Nuveen, LLC

$315 Billion
Q1 2025

A detailed history of Nuveen, LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 374,952 shares of TBPH stock, worth $3.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

374,952

Holding current value

$3.86 Million

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 12, 2025	BUY	$8.44 - $10.47 $3.16 Million - $3.93 Million	374,952 New	374,952 $3.35 Million

Others Institutions Holding TBPH

# of Institutions

127

Shares Held

46.5M

Call Options Held

600

Put Options Held

300

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$97.9 Million
14.29% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$76.7 Million
2.02% of portfolio
Newtyn Management, LLC New York, NY

4.76M
Shares

$49 Million
9.1% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$38.9 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$28.4 Million
2.79% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $687M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.

Account